Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
Status:
Recruiting
Trial end date:
2026-12-12
Target enrollment:
Participant gender:
Summary
Brain metastasis of lung cancer is one of the most important metastasis pathways in patients
with life-threatening diseases. This study explore the efficacy and safety of Tislelizumab
combining with platinum-containing drug chemotherapy in the first-line treatment of Lung
Adenocarcinoma With Asymptomatic Brain Metastatic. Meanwhile, Related biomarkers were
explored to provide theoretical basis for efficacy evaluation and resistance mechanism.